{
  "id": "5c6582207c78d69471000001",
  "type": "yesno",
  "question": "Is lucatumumab a polyclonal antibody?",
  "ideal_answer": "No, lucatumumab is a a monoclonal antibody against CD40.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/22861192"
  ],
  "snippets": [
    {
      "text": "A phase 1 study of lucatumumab, a fully human anti-CD40 antagonist monoclonal antibody administered intravenously to patients with relapsed or refractory multiple myeloma.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22861192",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "In this open-label, multicentre, phase 1 study a fully human anti-CD40 antagonist monoclonal antibody, lucatumumab, was evaluated in patients with relapsed/refractory multiple myeloma (MM).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22861192",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [],
  "exact_answer": "Yes"
}